Eryan Kong

9PUBLICATIONS
28CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Developmental genetics (incl. sex determination)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 13, 2026
Programmed Cell Death Protein 1-Interleukin-2 Bispecific Agents for Cancer Therapy.

Chang Xu, Tingxu Yan, Shuo Wen

|Sep 26, 2024
Palmitoylation regulates myelination by modulating the ZDHHC3-Cadm4 axis in the central nervous system.

Yanli Chang, Jiangli Zhu, Xiaopeng Li

|Sep 14, 2024
Inhibiting S-palmitoylation arrests metastasis by relocating Rap2b from plasma membrane in colorectal cancer.

Jiangli Zhu, Xize Cao, Zhenshuai Chen

|Feb 03, 2024
Palmitoylation is required for Sept8-204 and Sept5 to form vesicle-like structure and colocalize with synaptophysin.

Huicong Liu, Rong Tan, Jia Tong

|Dec 08, 2023
ALS-linked C9orf72-SMCR8 complex is a negative regulator of primary ciliogenesis.

Dan Tang, Kaixuan Zheng, Jiangli Zhu

|Dec 05, 2023
Palmitoylated Sept8-204 modulates learning and anxiety by regulating filopodia arborization and actin dynamics.

Huicong Liu, Peipei Yan, Can Wu

Pageof 2

Frequent Collaborators

6 joint publications

Yinming Liang

5 joint publications

Shiqian Qi

3 joint publications

Muding Rao

2 joint publications

Liaoxun Lu